Detalhe da pesquisa
1.
The role of surgery in patients with advanced gynaecological cancers participating in phase I clinical trials.
Eur J Gynaecol Oncol
; 33(2): 211-3, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-22611966
2.
Results of the phase IIa RADICAL trial of the FGFR inhibitor AZD4547 in endocrine resistant breast cancer.
Nat Commun
; 13(1): 3246, 2022 06 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35688802
3.
Author Correction: Results of the phase IIa RADICAL trial of the FGFR inhibitor AZD4547 in endocrine resistant breast cancer.
Nat Commun
; 14(1): 260, 2023 Jan 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-36650166
4.
An extended phase Ib study of epertinib, an orally active reversible dual EGFR/HER2 tyrosine kinase inhibitor, in patients with solid tumours.
Eur J Cancer
; 103: 17-23, 2018 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30196106
5.
Drug resistance reversal--are we getting closer?
Eur J Cancer
; 39(17): 2450-61, 2003 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-14602131
6.
Understanding Oestrogen Receptor Function in Breast Cancer and its Interaction with the Progesterone Receptor. New Preclinical Findings and their Clinical Implications.
Clin Oncol (R Coll Radiol)
; 28(1): 1-3, 2016 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-26548499
7.
Carcinoma-induced diffuse pulmonary haemorrhage.
Hosp Med
; 63(3): 176-7, 2002 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-11933824